Hints and tips:
...Until now the pharmaceutical industry has lived off pills and injections. Since the 19th century its scientists have used chemistry and biology to treat patients with drugs and vaccines....
...(FT, Stat) Diagnostic tests The WHO launched its first list of essential diagnostic tests, covering 58 common conditions and 55 global priority diseases such as HIV, TB and malaria....
...In the past year, Pfizer has spun off its animal health business, GSK has sold its drinks brands, and Johnson & Johnson and Novartis have divested diagnostics units....
...When Novartis revealed the sale of its blood diagnostics business last week, investment bankers could lick their lips at the prospect of fresh fees....
...Novartis’s chief executive indicated that the company’s vaccines and consumer health businesses would most likely be sold or partnered with other companies in the coming months, as he launched a fresh $5bn...
...But Chiron’s lack of success is one reason why the vaccines and diagnostics unit of Novartis is, by some distance, the worst performer of the group’s five divisions....
..., diagnostics and consumer health....
...Beyond core prescription drugs, the group sales at Alcon, its Sandoz generic subsidiary, vaccines and diagnostics, and over-the-counter medicines had all grown well in the third quarter....
...Other drug groups such as Roche and Bayer have shifted more modestly into devices, notably with diagnostics developed to identify diseases and improve the targeting of the medicines they have developed to...
...In vaccines and diagnostics, sales rose by 16 per cent to $632m, while consumer health sales rose by 8 per cent to $1.59bn....
...healthcare and diagnostics....
...In recent weeks, J&J took minority stakes in Crucell and Elan, two businesses that are active in vaccines and as well as drugs....
...The deal has reinforced and recentralised the focus of the combined group on speciality care medicines and diagnostics....
...Further ahead, the group’s expanding vaccines and diagnostics division reported good progress on developing a vaccine against the H1N1 influenza strain, including the use of new biotechnological cell-based...
...Pharmaceuticals returned to dynamic growth and gained market share in the second half of the year, while Vaccines and Diagnostics continued its double digit growth”, said Daniel Vasella, chairman and chief...
...In a move that analysts interpreted as paving the way to his eventual succession, Novartis named Jörg Reinhardt, head of vaccines and diagnostics, to take on day-to-day top executive functions in the newly...
...It has expanded into eyecare and vaccines, and substantially strengthened its existing status in generics, turning it into the second player by sales in the world....
...In the same way, Novartis has divested its chemicals, agricultural and nutrition operations, while expanding in pharmaceuticals, vaccines, diagnostics, generics and consumer health....
...Novartis, Pfizer and AstraZeneca have all made significant purchases to expand in vaccines over the past two years, while earlier this week, Roche purchased Piramed of the UK, a specialist cancer research...
...Excluding the charges of $209m associated with the acquisition ofChiron, the vaccine and diagnostics company, net income would have risen by 15 per cent....
...So our position is different than what J&J’s doing or what Novartis is doing, what Pfizer is doing…and what some other companies are doing....
International Edition